SATB2 expression was significantly associated with growth in peripancreatic fat in I-type tumours (p = 0.042), but not with any other clinicopathological factor, and there were no significant associations in PB-type tumours (Additional file 1: Table S1). This evidence concerns the gene SATB2 and neoplasm.